Try it
Psychiatry · Psychopharmacology: esketamine
Sample itemAn intranasal drug used with an oral antidepressant for treatment-resistant depression acts mainly through which mechanism?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. NMDA receptor antagonism (esketamine)
Esketamine, the S-enantiomer of ketamine, is an NMDA antagonist that produces rapid antidepressant action through glutamatergic signalling, and is given under supervision because of dissociation and blood pressure rise. It is used for treatment-resistant depression and acute suicidality.
Option by option
A. GABA-A potentiation
GABA-A potentiation is the benzodiazepine mechanism.
B. MAO inhibition
MAO inhibition is the mechanism of phenelzine and moclobemide.
C. NMDA receptor antagonism (esketamine) (correct)
Correct. Esketamine blocks NMDA receptors.
D. 5-HT3 antagonism
5-HT3 antagonism is the mechanism of ondansetron.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Psychiatry questions
- PsychopharmacologyLithium use during the first trimester of pregnancy is associated with which congenital…
- Psychotic disordersWhich of the following is a Schneiderian first-rank symptom of schizophrenia?
- Organic psychiatryAn elderly patient on a surgical ward develops acute confusion that fluctuates through t…
- Eating disordersA 17-year-old girl has a BMI of 15, amenorrhoea, lanugo hair, bradycardia and an intense…